<https://rdf.molmedb.upol.cz/reference/ref4161> <http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/membrane19>;
	<http://purl.org/ontology/bibo/doi> "10.1021/acsmedchemlett.0c00267"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM494475>;
	<http://purl.org/ontology/bibo/pmid> "33335660"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/bibliographicCitation> "Khalifa MM, Martorelli Di Genova B, McAlpine SG, Gallego-Lopez GM, Stevenson DM, Rozema SD, Monaghan NP, Morris JC, Knoll LJ, Golden JE.: Dual-Stage Picolinic Acid-Derived Inhibitors of <i>Toxoplasma gondii</i>. ACS Med Chem Lett, Volume 11 (12), 2020"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/method30>,
		<https://identifiers.org/molmedb/MM494342>,
		<https://identifiers.org/molmedb/MM494314> .
<https://rdf.molmedb.upol.cz/interaction/int1018610> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref4161> .
<https://rdf.molmedb.upol.cz/interaction/int1019714> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref4161> .
<https://rdf.molmedb.upol.cz/interaction/int1018638> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref4161> .
